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Abstract
Objective: We aim to evaluate the effectiveness of the brush biopsy technique using OralCDx ® (OralScan Labo-
ratories Inc., Suffern, NY) as a new method for early diagnosis and control of a “potentially malignant disorder” 
such as oral leukoplakia. Design of the study: We performed a study in which samples were taken using OralCDx 
® on 24 patients who visited the Master of Oral Medicine, Oral Surgery and Implantology of the University of 
Santiago de Compostela between February 2009 and May 2010. These patients presented clinical and histological 
lesions that were consistent with oral leukoplakia. We evaluated the relationship between the keratinization degree 
of the lesions and cell representation; the diagnosis obtained through OralCDx ® and biopsies; and sensitivity, 
specificity, positive predictive value (PPV) and negative predictive value (NPV). Results: 50% of patients were 
men and 50% women with an average age of 62.38 years. The Kappa coefficient relating keratinization of lesions and 
cell representation was 0.33, the OralCDx ® - biopsy diagnostic rate reached a Kappa value of 0.66, recording 72.7%, 
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sensitivity and 92.3% specificity, PPV was 88.8%, while NPV reached 80%. Conclusions: cytology sampling with 
OralCDx ® showed high sensitivity and specificity values, which make it a good tool for monitoring oral leukoplakia, 
but nowadays the most reliable method that allows us to confirm the exact diagnosis of the lesions and their anatomi-
cal and pathological characteristics still is conventional biopsy using a surgical scalpel.
Key words: OralCDx®, brush biopsy, oral leukoplakia.
Introduction
Oropharyngeal cancer is the sixth most common malig-
nancy worldwide (1). Among these cases, oral cancer ac-
counts for approximately 650,000 new cases each year 
(2). In Western countries it represents 2-4% of all malig-
nancies (3).  40% of head and neck tumors are Oral Squa-
mous Cell Carcinomas (OSCC) (2), amounting to 90% of 
the total of all those affecting the oral cavity (4).  Early 
detection of oral cancer in early stages affects the chanc-
es of survival significantly (1) thus improving the quality 
of life of these patients after undergoing treatment (3). 
Survival of OSCC patients has not improved over the 
last 30 years (5); the 5-year survival rate reaches 80% 
in cases detected at the initial stage, 40% in cases of 
regional involvement, and less than 20% in cases with 
distant metastasis (2). The delay in diagnosis is due to 
the fact that patients do not seek oral care for an unusual 
oral situation which is coupled with health professio-
nals’ lack of knowledge about these lesions (4). 
The aforementioned terms, such as “precancerous lesion”, 
“precancerous condition” or “intraepithelial neoplasia” 
have been replaced in May 2005 by the World Health Or-
ganization in collaboration with the Center for Oral Can-
cer and Precancer in the United Kingdom with the term 
‘Potentially Malignant Disorders”, which included oral 
leukoplakia among other illnesses (6). Early detection of 
these potentially malignant disorders is key in preventing 
an accumulation of alterations, such as dysplasia, increas-
ing their risk of a malignant transformation (7). 
Dentists therefore play an important role in early detec-
tion of malignant and premalignant conditions and should 
examine all patients at risk. (8,9). Biopsy is still the most 
accepted technique to reliably detect the nature of oral 
mucosal lesions, but it is a bloody test that implies un-
dergoing surgery and the resulting technical limitations 
for some professionals, in addition to the procedure’s 
psychological implications for patients (5). Due to this, 
it is important to develop new diagnostic techniques and 
instruments that can be used routinely (8). 
Oral exfoliative cytology is the microscopic study and 
interpretation of the characteristics of oral mucosal 
cells that are shed (naturally or artificially), by means of 
a simple, non-invasive and relatively painless technique 
that is well accepted by patients (4). Its use had been 
disregarded due to its low sensitivity level that is pat-
ent in the high number of false negatives (4), possibly 
due to inadequate sampling, technical errors and a poor 
design of sampling instruments (10). The implementa-
tion of “Cytobrush” in the 90’s has revived interest in 
oral exfoliative cytology since it increases the number 
of collected cells (11). Newer techniques such “brush 
biopsies” can assess cellular benignity or malignancy 
by computer-assisted analysis (5). Recently, we have be-
gun to use exfoliative cytology as more sophisticated 
methods of DNA and molecular analyses, which leads 
to improve its quality and reliability as a cancer diag-
nostic technique (4). 
This study aims to assess efficacy of a new brush biop-
sy technique, OralCDx ® (OralScan Laboratories Inc., 
Suffern, NY), as a new method for early diagnosis and 
monitoring a “potentially malignant disorder” such as 
oral leukoplakia.
Materials and Methods
We conducted a study (a controlled clinical trial), us-
ing samples obtained through OralCDx ® on 24 patients 
who visited the Master of Oral Medicine, Oral Surgery 
and Implantology of the University of Santiago de Com-
postela, referred by the SERGAS (Servizo Galego de 
Saúde - Galician Public Healthcare System), between 
February 2009 and May 2010 who showed clinical and 
histological lesions that were consistent with oral leuko-
plakia in different clinical forms.
-Selected lesions
Oral leukoplakia is a potentially malignant disorder 
with a prevalence of 0.2% to 3.6% of oral cavity white 
lesions, which amount to 24.8% of oral lesions (12). 
Warnakulasuriya et al. defined this lesion in May 2005, 
as a white plaque with an increasing questionable oral 
cancer risk after excluding other known diseases and 
disorders that do not increase the risk. Sometimes, red 
areas appear alongside the white ones; this is called 
erythroleukoplakia. Leukoplakia often presents a clear 
correlation with smoking habits, but there are some 
idiopathic cases (6). The annual average of malignant 
transformation is 1%. (12). 
-Method
OralCDx ® (OralScan Laboratories Inc., Suffern, NY), 
is a brush biopsy method with computer assisted sample 
analysis. It obtains cells from the three cell layers of the 
epithelium of the oral mucosa for a correct analysis (13). 
The Kit contains a brush cytology sampling tool, a pre-
coded glass slide, two pre-coded forms, two sachets of 
polyethylene alcohol fixative, a container for the sam-
ple holder and an envelope to send the samples (9). 
For sampling, we followed the steps indicated by the 
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manufacturer: filling forms (a copy to be sent out and 
a copy for the dentist); brush sampling by performing 
10 to 20 lateral or frontal rotations, in a representative 
area (never on an ulcer) until the area turns reddish or a 
light dotted hemorrhage; we then transferred the sample 
on to the pre-coded slide, placing the fixative to avoid 
contamination of the sample; the sample is then left to 
dry for 15 minutes and placed in the container and the 
envelope for shipment. In the laboratory the sample is 
stained with Papanicolaou tint (13); then it is scanned 
and analyzed microscopically using a computer with an 
image database containing different degrees of abnor-
mal cell morphology (14). The program is capable of de-
tecting two abnormal cells among thousands of normal 
cells (13). A cytopathologist reviews and interprets the 
data (14). The results are classified as atypical (cellular 
changes of uncertain diagnosis), positive for dysplasia 
or carcinoma, negative (normal cells) and inappropriate 
(incomplete transepithelial sample) (15). With all this 
data a report is issued and sent to the dentist.
The OralCDx® brush biopsy technique is a simple, mini-
mally invasive, relatively inexpensive, painless and has 
shown greater psychological acceptance by patients 
(3,13). With it, we can obtain complete transepithelial 
samples to perform adequate analysis of the lesion (2,13). 
No special training is required for its use thus favoring its 
acceptance among professionals (5,16). Local anesthesia 
is rarely necessary except in cases of ulcerated lesions in 
which its use is indicated, since sampling of these areas 
often results in greater discomfort for the patient (13). 
Besides the different variables appearing on the form 
(color, location, symptoms, etc.) the dentist responsible 
for the cytological samples subjectively assessed the 
keratinization degree of the lesions. 
We decided to consider as low-keratinized lesions, re-
gardless of the oral cavity area in which they were locat-
ed, those lesions that had a similar color to that of healthy 
oral mucosa. Moderately keratinized lesions were those 
having a whitish appearance but that were located in 
areas of the oral cavity showing little or no keratiniza-
tion (e.g. buccal mucosa) and highly keratinized lesions 
were those showing a high degree of keratinization and 
were located in keratinized areas (e.g. hard palate).
All patients had a sample taken with a surgical scalpel 3 
weeks prior or after sampling with the OralCDx ® kit to 
compare our results.
-Inclusion-Exclusion criteria
All patients were informed about the procedure they 
were to undergo, they were asked to sign a consent 
form authorizing sampling. They also had to author-
ize the performance of a conventional biopsy using a 
surgical scalpel.
We excluded patients who did not sign the consent form 
for both samples; those who had undergone treatment 
before the lesion and those whose lesions had a different 
diagnosis from leukoplakia. All samples were taken by 
the same dentist and analyzed by the same pathologist.
The development of this study was approved by the Ethics 
Committee of the Faculty of Medicine and Dentistry, 
University of Santiago de Compostela.
We used the computer program SPSS 15.0 for Windows 
(Inc., Chicago, USA) to analyze the different variables 
of our study, using contingency tables to calculate the 
Kappa index and assess the correlation between test re-
sults using OralCDx ® and conventional biopsy and the 
keratinization degree and cell representation. Calcula-
tions of sensitivity, specificity, positive predictive value 
(PPV) and negative predictive value (NPV) were per-
formed using STATAtm software 10.1 for Windows.
Results
Of the 24 patients included in the study, 12 (50%) were 
men and 12 (50%) women. We took a single sample 
from each patient. Local anesthesia was not required in 
any of the cases. Their age ranged between 40 and 82 
years, with an average age of 62.38 + / - 12.14 years. 19 
patients (79.16%) were initially diagnosed with oral leu-
koplakia and 5 with erythroleukoplakia (20.83%). The 
most frequent location of lesions in our study was the 
lateral border of tongue, appearing in 8 cases (33.3%), 
which was followed by buccal mucosa in 4 cases (16.7%). 
In our cases, 11 (45.8%) of the lesions showed a flat ap-
pearance and 13 (54.2%) were verrucose. 15 (62.5%) pa-
tients were smokers or had a history of smoking, while 
9 of these (60%) drank alcohol regularly.
Concerning the degree of keratinization, we found 6 
cases (25%) of highly keratinized lesions, 14 (58.3%) 
were moderately keratinized and 4 lesions (16.7%) were 
slightly keratinized. Table 1 shows all data concerning 
the characteristics of the lesions.
As regards to the OralCDx ® technique, in 16 (66.7%) 
of cases we obtained cells from all 3 layers of the 
epithelium (superficial, intermediate and basal), 
while in 4 (16.7%) cases we found intermediate and 
superficial cells and in 4 (16.7%) we only obtained 
superficial cells.
In the analyses reports we found that the tests were ne-
gative (no cellular alterations) in 15 cases (62.5%) and 
that there was atypia in the remaining 9 cases (37.5%). 
Local anesthesia during the sampling procedure was 
not necessary in any of the cases in our study.
The results of surgical scalpel biopsies were classified 
as negative (without epithelial alteration) in a total of 13 
cases (54.2%); atypical (mild-moderate dysplasia) in 11 
cases (45.8%).
By correlating these two variables, test results using 
OralCDx ® and conventional biopsies, and taking into 
account all the samples, we obtained values of 72.7% 
sensitivity and 92.3% specificity. PPV was 88.8% (95% 
CI 50.6-99.4%), while NPV was 80% (95% CI 51.3-
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94.6%). Upon calculating correlation between the re-
sults obtained with OralCDx ® and biopsies we obtained 
a Kappa value of 0.66, which showed good correlation.
Finally, we analyzed the keratinization degree in rela-
tion to the difficulty of obtaining a complete sample 
and we observed that in the total number of cases of 
low-keratinized lesions (4 samples) we obtained a com-
plete sample; in 4 (28.5%) of the 14 cases with mod-
erately keratinized lesions we only obtained superficial 
and intermediate cells; while in 4 of 6 (66.6%) cases of 
highly-keratinized lesions we only managed to obtain 
an incomplete sample. The Kappa value in this case was 
0.33 thus we recorded a low correlation, however it was 
very close to the correct values (0.4).
Table 1. Clinical characteristics of lesions.

Diagnosis
Leukoplakia
Erythroleukoplakia 
19 (79’16%) 
5 (20’83%) 
Appearance
Flat 
Verrucose
Ulceration
Yes
No
11 (45’8%) 
13 (54’2%) 
4 (16’6%) 
20 (83’3%) 
Location
Buccal Mucosa 
Lateral of tongue 
Ventral area 
Back of Tongue 
Gums 
Retromolar trigone 
Labial and alveolar 
Hard palate 
4 (16’7%) 
8 (33’3%) 
3 (12’5%) 
3 (12’5%) 
2 (8’3%) 
2 (8’3%) 
1 (4’2%) 
1 (4’2%) 
Duration of lesion
< 6 months 
6 months - 1 year 
> 1 year 
Unknown 
1 (4’2%) 
5 (20’8%) 
16 (66’7%) 
2 (8’3%) 
Size of lesión
5-10 mm 
10-20 mm 
More than 20 mm 
8 (33’3%) 
8 (33’3%) 
8 (33’3%) 
Discussion
In our study we found that the lateral border of the 
tongue was the most frequent location of the lesions ap-
pearing in 8 cases (33.3%), followed by buccal mucosa 
in 4 cases (16.7%). Meanwhile other authors state that 
the most common location is the buccal mucosa with 
rates varying between 31 and 22%, followed by the 
lateral border of tongue (15-22%). (1,13,16). This diffe-
rence may be due to the small size of our sample com-
pared with that of other authors (1,13,16).
Of all our patients, 15 (62.5%) were smokers or had a 
history of smoking which indicates the relationship be-
tween the occurrence of these injuries and smoking. 
In our study and in those by other authors we found 
that samples were taken mainly in predominantly 
white lesions with percentages ranging from 40-65% 
(1,13,16,17).
As regards to the cellularity obtained by sampling with 
the OralCDx ® kit; in 8 cases (33.3%) cells we did not 
obtain cells from the 3 layers of the epithelium; 4 of 
which (50%) were taken at the beginning of our study, 
which is normal due to our initial unfamiliarity with 
the technique. (13,15). The average of incorrect samples 
usually ranges between 2% and 6% (15). This relatively 
low percentage of incomplete samples was due to the 
rigid design of the brush for adequate sampling (13,18). 
Upon evaluating the difficulty in obtaining complete 
samples in relation to the lesion’s keratinization degree, 
we noted that in 4 (66.6%) of 6 highly-keratinized le-
sions we could not obtain cells from the 3 layers of the 
epithelium, while in 4 (16.7%) of 14 cases of moderate-
ly-keratinized lesions we failed to obtain a complete 
sample, recording a Kappa value of 0.33, which was 
very close to matching correct correlation values for 
this variable (0.4).  Many authors have indicated that a 
high keratinization degree in some lesions can be con-
tradictory to the use of this technique since it hinders us 
from securing sufficient cellularity to perform adequate 
analysis (8,11,13,15). We could then consider, in these 
cases, taking a sample using a scalpel which would al-
low for a correct analysis of these lesions.
Correlating the results of OralCDx ® and conventional 
biopsy we recorded a Kappa value of 0.66, which in-
dicated a high concordance level. The sensitivity value 
for this test was 72.7% and 92.3% specificity. Both va-
lues are close to those found in other publications which 
range between 70-100% for sensitivity and between 
90-100% specificity (11,13,15-17). We found one false 
positive (11.1%). 
This relatively low sensitivity may be due to the fact 
that we found 3 (20%) false negatives. One of these 
cases showed a high degree of dysplasia. It is important 
to note that basal layer cell representation layer in this 
specific patient was insufficient. In fact, if we were to 
eliminate all 8 cases in which cell representation was 
incomplete we would obtain a sensitivity of 87.5% while 
the specificity would remain the same.  PPV was 88.8% 
and NPV 80%, values that somewhat corroborate the 
reliability of our test. These values vary in other publi-
cations, ranging between 38-88% for PPV and 60-100% 
in the case of NPV (14).
In most studies, a biopsy was taken only in patients who 
showed atypical cytology results. This can cause errors 
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in the studies of these authors, in terms of sensitivity, 
specificity, PPV and NPV calculations (18). Authors 
such as Scheifele et al., indicate that they performed bi-
opsies only in cases of atypia, with a delay of 75 to 292 
days, which may cause major histopathologic changes 
in the lesion during that lapse of time. (15). In our study 
no more than 21 days passed between sampling with 
one technique or the other.
The main problem we found was that with the OralCDx ® 
kit we failed to establish diagnoses that allowed us to 
identify the lesion, given that it only allows us to per-
form an assessment of the cellular representation, thus 
it may be considered as a method to monitor lesions. 
Nowadays, to obtain definitive certainty of diagnosis it 
is still necessary to use a conventional scalpel biopsy (2). 
Another problem we observed was scarceness of patholo-
gists who are specialized in the analysis of these samples, 
as has been previously noted by other authors (13). Often, 
reference laboratories have a long delay in issuing results 
with deadlines ranging from 30 to 120 days. 
Another problem noted by some authors is sampling 
with OralCDx ® in an inflammatory pathology such as 
lichen planus or pemphigus, since these conditions of-
ten result in the existence of a greater number of false 
positives, as a result of cell morphology which has been 
altered by inflammation. (8,13).
Multiple researches are underway to try to prove the fu-
ture applications of this methodology in cytomorfome-
try, molecular analysis and DNA collection and analysis 
from liquid-based cytology. (3-5,8,11,15,19,20).
Our conclusion is that, although cytological sampling 
with OralCDx ® (OralScan Laboratories Inc., Suffern, 
NY), presents high sensitivity and specificity values 
that make it a good tool for monitoring oral leukopla-
kia, nowadays, the most reliable method to confirm 
the exact diagnosis of lesions and their histopathologic 
characteristics biopsy is still conventional biopsy by 
surgical scalpel.
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